A. Louw et al., Inhibition of cytochrome P450c11 by biogenic amines and an aziridine precursor, 2-(4-acetoxyphenyl)-2-chloro-nmethyl-ethylammonium chloride, ENDOCRINE R, 26(4), 2000, pp. 729-736
The interaction of several biogenic amines and Compound A (2-(4-acetoxyphen
yl)-2-chloro- N-methyl-ethylammonium chloride), an analogue of the active s
ubstance in a HPLC fraction isolated from the shrub, Salsola tuberculatifor
mis Botsch., with cytochrome P450c11 was investigated. Noradrenaline, octop
amine and Compound A inhibited the type I DOC induced difference spectrum o
f P450c11 and elicited a type II difference spectrum when added alone. The
Ks-values for noradrenaline, octopamine, and Compound A were 0.8 mM, 0.16 m
M and 0.36 mM, respectively. Dopamine, adrenaline and synephrine did not in
teract with, or inhibit, P450c11. Further investigation of Compound A indic
ated that it is a mixed inhibitor of sheep P450c11 with a stronger competit
ive (Kic = 106-110 muM) than uncompetitive (Kiu = 667-737 muM) element, and
that it inhibits the conversion of deoxycorticosterone to corticosterone b
y human 11 beta -hydroxylase and aldosterone synthase with EC50 values of 9
7 muM and 190 muM, respectively, in fetal calf serum.